NDC 59762-2350 – Ethosuximide
Ethosuximide 250 mg/5mL · Solution · Oral
Product NDC59762-2350
Product details
- Brand name
- Ethosuximide
- Generic name
- Ethosuximide
- Labeler
- Mylan Pharmaceuticals Inc.
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- ANDA · ANDA080258
- Marketed since
- February 21, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Anti-epileptic Agent
Active ingredients
- Ethosuximide 250 mg/5mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 59762-2350-6 | 1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-6) / 474 mL in 1 BOTTLE, PLASTIC | Feb 21, 2020 |
| 59762-2350-7 | 1 BOTTLE, PLASTIC in 1 CARTON (59762-2350-7) / 474 mL in 1 BOTTLE, PLASTIC | Jul 1, 2022 |
Other Ethosuximide products
- 69452-152 Ethosuximide 250 mg/1 · Capsule, Liquid Filled · Bionpharma Inc.
- 63629-8005 Ethosuximide 250 mg/1 · Capsule, Liquid Filled · Bryant Ranch Prepack
- 68999-064 Ethosuximide 250 mg/5mL · Solution · Chartwell Governmental & Specialty RX, LLC.
- 62135-064 Ethosuximide 250 mg/5mL · Solution · Chartwell RX, LLC
- 62135-790 Ethosuximide 250 mg/1 · Capsule · Chartwell RX, LLC
- 42806-708 Ethosuximide 250 mg/1 · Capsule · Epic Pharma, LLC
- 42806-711 Ethosuximide 250 mg/1 · Capsule · Epic Pharma, LLC
- 0121-0670 Ethosuximide 250 mg/5mL · Solution · PAI Holdings, LLC dba PAI Pharma
- 64380-878 Ethosuximide 250 mg/1 · Capsule · Strides Pharma Science Limited